AbbVie, Harpoon Therapeutics enter immuno-oncology collaboration; deal expanded to include up to six new targets
In its first collaboration since its founding in 2015, Harpoon Therapeutics is teaming up with AbbVie Inc. in the area of immuno-oncology therapies.
- Includes Contract
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com